On a preliminary basis, Inspire Medical Systems (NYSE:INSP)
expects Q1 revenue of ~$21.3M, up 31% from a year ago and slightly
below consensus of $22.6M. U.S. revenue should be ~$19.3M (+34%).
Due to COVID-19 disruptions, management is withdrawing 2020 guidance issued on February 25.
https://seekingalpha.com/news/3560285-inspire-medical-sees-31-increase-in-q1-revenue
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.